PFE News 32.04 04/29/2014 06:05:10 Pfizer Inc (PFE)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pfizer Inc (PFE) 32.04 $PFE


Report: Health exchanges' drug coverage confusing
By CARLA K. JOHNSON - AP - 1 min ago
CHICAGO (AP) — The hunt for a health plan that would cover a particular drug or a favorite doctor proved particularly frustrating for many consumers navigating the new insurance exchanges under the federal government's health care overhaul, according to a report released Monday.

'Fast Money' Recap: The Problem With Growth Stocks
at The Street - 2 hrs 4 mins ago
The trading panel wonders why Facebook is having a good quarter when Google has been selling off.


Asia markets mixed, Australia touches 6-year high
The Associated Press - AP - Mon Apr 28, 10:42PM CDT
HONG KONG (AP) — Asian stocks were mixed Tuesday, with Australia's benchmark briefly touching a six-year high while other markets lacked a clear focus as investors stayed on the sidelines ahead of a number of economic data reports later this week.
2 Comments

Dow Climbs 87 As Bank of America and Pfizer Dominate Headlines
Jack Kramer and Nick Martell, The Motley Fool - Motley Fool - Mon Apr 28, 10:00PM CDT
We know. Your schedule is packed this week with NHL playoff games and early spring BBQ shenanigans. Now add to your list the two-day Federal Reserve policy meeting, a whole bunch of headline earnings reports, and Friday's big April jobs report....

Pfizer Could Buy These 30 Biotechs Instead of One AstraZeneca (but It Won't)
Brian Orelli, The Motley Fool - Motley Fool - Mon Apr 28, 6:26PM CDT
The rumors are true. Pfizer offered to buy AstraZeneca for $76.62 per share, valuing the company around $100 billion. A hundred billion! To put that in perspective, instead of buying AstraZeneca, Pfizer could buy these 30 biotech...

China Rule Change Further Opens Yuan To World Markets
at Investor's Business Daily - Mon Apr 28, 5:31PM CDT
Big purses started spilling open around the globe in the past week. GlaxoSmithKline (GSK), Novartis (NVS) and Eli Lilly (LLY) announced a series of business swaps valued at $19.9 billion. AstraZeneca (AZN) straight-armed a $98 billion offer from...

Merck & Co., Inc. Earnings: Is Growth Around the Corner?
Dan Caplinger, The Motley Fool - Motley Fool - Mon Apr 28, 5:30PM CDT
On Tuesday, Merck will release its quarterly report, and investors have sent the stock soaring to multiyear highs recently. Even though Merck's revenue and earnings aren't likely to grow from year-ago levels, Merck is showing promise in its...

Most active New York Stock Exchange-traded stocks
AP - Mon Apr 28, 5:13PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:

Final Glance: Pharmaceuticals companies
AP - Mon Apr 28, 5:13PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:

Bank of America, AstraZeneca are big market movers
AP - Mon Apr 28, 4:52PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:

Business Highlights
By The Associated Press - AP - Mon Apr 28, 4:38PM CDT
___


Stocks higher on deal hopes; BofA sinks
By KEN SWEET - AP - Mon Apr 28, 4:17PM CDT
NEW YORK (AP) — It was a choppy ride for the stock market on Monday that ended with major U.S. indexes closing mostly higher.

Why Susser Holdings, Furiex Pharmaceuticals, and AstraZeneca Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Mon Apr 28, 4:15PM CDT
Another "Merger Monday" lit a fire beneath investors and the S&P 500 with merger and acquisition rumblings and announcements signaling to investors that businesses are still willing to take on risks in order to expand. The end result was yet...

How the Dow Jones industrial average did Monday
The Associated Press - AP - Mon Apr 28, 4:08PM CDT
It was a choppy day on the stock market on Monday that ended with major U.S. indexes closing mostly higher.

Why Merck Will Move the Dow Tomorrow
Dan Caplinger, The Motley Fool - Motley Fool - Mon Apr 28, 3:30PM CDT
The Dow Jones Industrials climbed 87 points on Monday, as investors were relieved not to have seen some of their immediate geopolitical fears pan out over the weekend. Part of the excitement in today's market action came from Dow component Pfizer...

Nasdaq Recovers After Early Weakness; Apple Rallies Again
at Investor's Business Daily - Mon Apr 28, 3:28PM CDT
The Dow Jones industrial average and S&P 500 ended higher Monday, and the Nasdaq recovered early losses in a resilient performance. At the close, the Nasdaq fell less than 0.1% lower after being down by as much as 1.5%. It's still holding above its...

Why Pfizer (PFE) and AstraZeneca (AZN) Stocks Are Up Today
at The Street - Mon Apr 28, 3:26PM CDT
Pfizer (PFE) and AstraZeneca (AZN) rose Monday amid more takeover talks between the two pharmaceutical companies.

U.S. Stocks Mount Midday Turnaround to Close Higher, Bank of America Plunges
at The Street - Mon Apr 28, 3:19PM CDT
U.S. stocks turned around earlier losses Monday and closed in the green, while shares of banking giant Bank of America plunge on a capital blunder.


Late push leaves US stock market mostly higher
AP - Mon Apr 28, 3:14PM CDT
NEW YORK (AP) — Stocks are ending a choppy day mostly higher as investors balanced enthusiasm over a possible merger in the health care industry with bad news from Bank of America.

Pfizer still pursuing AstraZeneca after 2nd rebuff
By DANICA KIRKA and LINDA A. JOHNSON - AP - Mon Apr 28, 4:10PM CDT
LONDON (AP) — Pfizer Inc. was turned down twice by fellow drugmaker AstraZeneca PLC, but the maker of Viagra and Lipitor said Monday that its proposed $100 billion acquisition makes sense for shareholders of both companies, and it's considering its next steps.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 139

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 250

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 254

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 353

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 155

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 127

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 321

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 143

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 313

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading

Top 5 Most Recently Viewed Articles

Explore Rob Zombie's Unique Art Exhibition in Kent Connetcticut

Updated Category News Views 226

Rob Zombie's Art Exhibition: "What Lurks on Channel X?" Morrison Gallery is excited to announce the first-ever exhibition of Rob Zombie's provocative artwork titled "What Lurks on Channel X?" This unique showcase celebrates the artistry of the renowned rock musician and filmmaker. The exhibition is set to open for public viewing, bringing an array of Zombie's dynamic...

Continue Reading
Unlocking Over $11M Annually: Modernizing Industrial Systems

Updated Category News Views 237

Revolutionizing Industrial Automation for Greater Savings Modernization is key for industrial companies seeking to thrive, especially in today’s competitive landscape. A recent enlightening study has unveiled a significant opportunity: organizations can potentially reclaim $11.28 million annually by shifting away from outdated closed automation systems. This information...

Continue Reading
Investors on Alert: Security Class Action for StubHub Holdings

Updated Category News Views 159

Investors on Alert: Security Class Action for StubHub Holdings National shareholder rights firm Hagens Berman is reaching out to investors of StubHub Holdings, Inc. (NYSE: STUB) following news of a significant deadline in a prospective securities class action. This legal inquiry focuses on whether the Initial Public Offering (IPO) documents from StubHub, made available to...

Continue Reading
Melexis Enhances Shareholder Value with Strategic Buyback

Updated Category News Views 240

Melexis Enhances Shareholder Value with Strategic Buyback Melexis continues to demonstrate its commitment to enhancing shareholder value with an active share buy-back program. Following the announcement made late last year regarding the initiation of this program, the company recently announced the purchase of 47,500 shares on Euronext Brussels during a specified period...

Continue Reading
John Manimas Unveils Breakthrough in Ancient Geometry Puzzle

Updated Category News Views 249

The Remarkable Discovery of John Manimas John Manimas, renowned for his engaging exploration of mathematical mysteries, has recently announced a significant advancement in the realm of geometry. He claims to have discovered a positive solution to the age-old Pythagorean riddle: the question of whether one can construct a circle that is exactly equal in area to a given...

Continue Reading